Skip to NavigationSkip to content

Pharmafile - Sales and Marketing

Giliad's Yesarta becomes second FDA-approved CAR T treatment and AstraZeneca admits efficacy data for an acquired cancer drug was fabricated. Check...
Israeli drugmaker Teva has again become embroiled in a scandal investigated by the Ontario government for allegedly bribing pharmacies to stock its...
Eli Lilly has announced it is to partner up with CureVac to leverage its proprietary RNActive technology in order to develop and commercialise up...
Vir biotech has managed to drum up $500 million in financing, acquire a company and strike agreements with two companies to develop clinical and...

Features

Peter Naredi, of ECCO, explores how a multi-dimensional approach is necessary to ensure that patients receive access to the most important medical...

Appointments

NHS Scotland has revealed the appointment of Professor David Crossman as its new Chief Scientist, after advertising externally to fill the...

Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches